EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation

Wojciech G Lesniak iD, Srikanth Boinapally, Gabriela Lofland, Zirui Jiang, Catherine A Foss, Babak Behman Azad, Anna Jablonska, Mauro A Garcia, Maria Brzezinski, Martin G Pomper

International Journal of Nanomedicine · 2024-05 · Volume 19 · 4995-5010

DOI: 10.2147/ijn.s454128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024-05. Verfasst von Wojciech G Lesniak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, 21287, USA. Hauptthemen laut MEDLINE: Antigens, Surface, Dendrimers, Glutamate Carboxypeptidase II, Prostatic Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, SurfaceDendrimersGlutamate Carboxypeptidase IIProstatic NeoplasmsAnimalsHumansMaleMiceCell Line, TumorDrug Delivery SystemsPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

PAMAM dendrimerPSMAprostate cancertargeted cancer treatmenttheranostics

Substanzen

Antigens, SurfaceDendrimersFOLH1 protein, humanGlutamate Carboxypeptidase IIPAMAM Starburst

Autor:innen und Institutionen

  • Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, 21287, USA.
  • Institute for Cell Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.
  • Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

ORCID-Profile: Wojciech G Lesniak

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Lesniak, W. G., Boinapally, S., Lofland, G., Jiang, Z., Foss, C. A., Behman Azad, B., Jablonska, A., Garcia, M. A., Brzezinski, M., & Pomper, M. G. (2024). Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation. International Journal of Nanomedicine, Volume 19, 4995-5010. https://doi.org/10.2147/ijn.s454128

Vancouver

Lesniak WG, Boinapally S, Lofland G, Jiang Z, Foss CA, Behman Azad B, et al. Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation. International Journal of Nanomedicine. 2024;Volume 19:4995-5010. doi:10.2147/ijn.s454128

BibTeX
@article{Lesniak2024,
  author = {Lesniak, Wojciech G and Boinapally, Srikanth and Lofland, Gabriela and Jiang, Zirui and Foss, Catherine A and Behman Azad, Babak and Jablonska, Anna and Garcia, Mauro A and Brzezinski, Maria and Pomper, Martin G},
  title = {Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  volume = {Volume 19},
  pages = {4995--5010},
  doi = {10.2147/ijn.s454128}
}
Kostenlos starten →